Stay updated on Tucatinib Combo Efficacy in HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Tucatinib Combo Efficacy in HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tucatinib Combo Efficacy in HER2+ Breast Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The website has been updated from version v2.10.2 to v2.10.3.
    Difference
    0.3%
    Check dated 2024-09-04T02:01:23.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    New content was added on August 21, 2024, following the deletion of previous content on July 30, 2024.
    Difference
    0.7%
    Check dated 2024-08-28T01:40:10.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.
    Difference
    0.3%
    Check dated 2024-08-13T21:26:18.000Z thumbnail image
  5. Check
    35 days ago
    No Change Detected
  6. Check
    42 days ago
    Change Detected
    Summary
    New content was added on July 30, 2024, while previous content was removed on July 3, 2024.
    Difference
    0.3%
    Check dated 2024-07-30T20:25:18.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    The website has added new functionality for viewing and comparing study record versions in the latest update (v2.10.0), replacing the previous version (v2.9.7).
    Difference
    6%
    Check dated 2024-07-23T13:29:51.000Z thumbnail image
  8. Check
    57 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7 from v2.9.6.
    Difference
    0.3%
    Check dated 2024-07-16T05:51:19.000Z thumbnail image

Stay in the know with updates to Tucatinib Combo Efficacy in HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tucatinib Combo Efficacy in HER2+ Breast Cancer Clinical Trial page.